Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,726 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

NCT04033367

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Investigational Site Number :8400012 North Little Rock, Arkansas, United States

Investigational Site Number :8400002 Redwood City, California, United States

Investigational Site Number :8400001 Rolling Hills Estates, California, United States

Investigational Site Number :8400013 Colorado Springs, Colorado, United States

View all 42 locations

View Trial Details

Completed

Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen

NCT06085963

Conditions: Allergic Rhinitis Due to Pollen, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

NCT04823130

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Investigational Site Number 8400001 Miami, Florida, United States

Investigational Site Number 8400002 East Windsor, New Jersey, United States

Investigational Site Number 2760001 Münster, Germany

View Trial Details

Completed

Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases

NCT04765722

Conditions: Asthma, Bronchial Diseases, Chronic Cough, +13 more
Locations: McMaster University Hamilton, Ontario, Canada

View Trial Details

Completed

The Effect of Thyme Oil in Asthmatic Patients

NCT06664671

Conditions: Asthma, Asthma Patients, Bronchial Diseases, +11 more
Locations: A patient in eastern Turkey Batman, Turkey (Türkiye)

View Trial Details

Completed

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

NCT04088721

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Taipei Medical University Taipei, Taiwan

View Trial Details

Completed

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

NCT04718870

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Investigational Site Number :8400002 Los Angeles, California, United States

Investigational Site Number :8400001 Denver, Colorado, United States

Investigational Site Number :8260001 Sheffield, United Kingdom

View Trial Details

Completed

Detection of Viral Particels in Urticaria Patients

NCT03151902

Conditions: Chronic Disease, Chronic Urticaria, Disease Attributes, +10 more
Locations: Emek Medical Center Afula, Israel

View Trial Details

Completed

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China

NCT05624112

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital) Guangzhou, Guangdong, China

View Trial Details

Completed

Dupilumab in Japanese Patients With Atopic Dermatitis

NCT04678882

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Investigational Site Number : 3920011 Nagoya, Aichi-ken, Japan

Investigational Site Number : 3920014 Toyoake-shi, Aichi-ken, Japan

Investigational Site Number : 3920015 Fukutsu-shi, Fukuoka, Japan

Investigational Site Number : 3920001 Hiroshima, Japan

View all 19 locations

View Trial Details